Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYTO

Altamira Therapeutics (CYTO) Stock Price, News & Analysis

Altamira Therapeutics logo

About Altamira Therapeutics Stock (NASDAQ:CYTO)

Advanced Chart

Key Stats

Today's Range
$0.30
$0.43
50-Day Range
$0.30
$0.52
52-Week Range
$0.30
$1.53
Volume
753,013 shs
Average Volume
315,542 shs
Market Capitalization
$1.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYTO Stock News Headlines

Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
Altamira Therapeutics Ltd. (CYTOF)
Altamira Therapeutics Ltd (CYTOF)
See More Headlines

CYTO Stock Analysis - Frequently Asked Questions

Shares of Altamira Therapeutics reverse split on the morning of Wednesday, December 13th 2023.The 1-20 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, December 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Altamira Therapeutics investors own include Plug Power (PLUG), Aridis Pharmaceuticals (ARDS), Soligenix (SNGX), Chemomab Therapeutics (CMMB), CNS Pharmaceuticals (CNSP), Cara Therapeutics (CARA) and Draganfly (DPRO).

Company Calendar

Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYTO
CIK
1601936
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.43
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$320 thousand
Price / Sales
3.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.56 per share
Price / Book
0.07

Miscellaneous

Outstanding Shares
3,400,000
Free Float
2,958,000
Market Cap
$1.02 million
Optionable
Not Optionable
Beta
1.80
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CYTO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners